Acasti Pharma Stock Forecast 2022

During the day the stock fluctuated 9.31% from a day low at $1.39 to a day high of $1.52. Close price at the end of the last trading day (thursday, 18th nov 2021) of the acst stock was $1.40.

2esg--zb4hbq3m

What is acst stock forecast (i.e., prediction)?

Acasti pharma stock forecast 2022. Acasti pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is tuesday, february 8th, 2022 based off prior year's report dates. Find the latest news for acasti pharma stock on our page and stay on top of the game. Stock forecast 2025, 12 predictions are offered for each month of 2025 with average acasti pharma inc.

Acst stock has since managed to climb to highs of $0.4177 this week. As of 2021 november 27, saturday. Acasti pharma has generated ($0.45) earnings per share over the last year (($0.45) diluted earnings per share).

Acasti pharma provides business update for the second quarter of fiscal 2022. Acasti pharma announces annual stock option grants. The average acasti pharma inc.

Acst will report 2021 earnings on 06/29/2022. Analyst estimates, including acst earnings per share estimates and analyst recommendations. 93 rows about the acasti pharma, inc.

They're working on a phase two test of a new drug, but the results are delayed, which has hammered the stock by half, though it's moved up 16% today. The stock had previously closed at c$1.98. Interested in getting the full scoop on acst, including earnings and dividends, stock forecast, buy or sell analysis and key stats?

Conference call to be held on wednesday, november 10th at 1:00 p.m. Shares in acasti pharma inc are currently priced at $1.37. Search stock, fx pair, crypto, or commodity.

The company traded as low as c$1.92 and last traded at c$1.92, with a volume of 7268 shares traded. The stock has a market capitalization of c$85.92 million and a pe [] read more. Looking to buy or sell acasti pharma, inc.

Get our premium forecast now, from only $8.49! Another one of the biotech penny stocks under $1 is acasti pharma. Volume fell on the last day along with the stock, which is actually a good sign as.

Since then, acst stock has decreased by 58.8% and is now trading at $1.27. Investors also form their own opinion of acasti pharma's value that differs from its market value or its book value, called intrinsic value, which is acasti pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value.

This is 7.89% less than the trading day before wednesday, 17th nov 2021. Stock forecast of 1.88, a high forecast of 1.88, and a low forecast of 1.88. Stock forecast 2022 represents a 0.1% increase from the last price of 1.86000001430511.

(“acasti” or the “company”) (nasdaq: The company focuses on biotech treatment development. Based on acst analyst price targets, acst stock forecast is $2.00 (for a year.

Earnings estimate revisions for acasti. Acasti pharma schedules second quarter fiscal 2022 business update conference call. At that level they are trading at 91.87% premium to the analyst consensus target price of 0.00.

The company is targeting three underserved orphan diseases: